Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Reduced TRPS1 leads to increased STAT3 and SOX9 in hair follicles, affecting hair growth.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

A person with a specific gene mutation had extra teeth, unique jaw and hair features not seen before in this condition.

Trps1 is essential for proper hair follicle development.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Certain alkaloids could help create new coronavirus drugs.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

The document's content couldn't be understood or processed.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

TRPS1 is crucial for bone, kidney, and hair follicle development.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.